285 related articles for article (PubMed ID: 33381923)
1. The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis.
Liu H; Yang D; Chen X; Sun Z; Zou Y; Chen C; Sun S
Cancer Med; 2021 Feb; 10(3):1043-1056. PubMed ID: 33381923
[TBL] [Abstract][Full Text] [Related]
2. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
[TBL] [Abstract][Full Text] [Related]
5. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
[No Abstract] [Full Text] [Related]
6. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Lièvre A; Turpin A; Ray-Coquard I; Le Malicot K; Thariat J; Ahle G; Neuzillet C; Paoletti X; Bouché O; Aldabbagh K; Michel P; Debieuvre D; Canellas A; Wislez M; Laurent L; Mabro M; Colle R; Hardy-Bessard AC; Mansi L; Colomba E; Bourhis J; Gorphe P; Pointreau Y; Idbaih A; Ursu R; Di Stefano AL; Zalcman G; Aparicio T;
Eur J Cancer; 2020 Dec; 141():62-81. PubMed ID: 33129039
[TBL] [Abstract][Full Text] [Related]
8. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
[TBL] [Abstract][Full Text] [Related]
9. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
[TBL] [Abstract][Full Text] [Related]
11. Impact of COVID-19 Outbreak through Telemedicine Implementation on Data Reporting During Oncology Clinical Trials.
Bouleftour W; Daguenet E; Tinquaut F; Magne N
Cancer Invest; 2021 Jan; 39(1):15-20. PubMed ID: 33258396
[TBL] [Abstract][Full Text] [Related]
12. Supportive care in patients with cancer during the COVID-19 pandemic.
Aapro M; Lyman GH; Bokemeyer C; Rapoport BL; Mathieson N; Koptelova N; Cornes P; Anderson R; Gascón P; Kuderer NM
ESMO Open; 2021 Feb; 6(1):100038. PubMed ID: 33421735
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive review of implications of COVID-19 on clinical outcomes of cancer patients and management of solid tumors during the pandemic.
Madan A; Siglin J; Khan A
Cancer Med; 2020 Dec; 9(24):9205-9218. PubMed ID: 33078903
[TBL] [Abstract][Full Text] [Related]
14. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Iannizzi C; Chai KL; Valk SJ; Kimber C; Dorando E; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013600. PubMed ID: 34013969
[TBL] [Abstract][Full Text] [Related]
15. Management of urologic cancers during the pandemic and potential impact of treatment deferrals on outcomes.
Mian BM; Siddiqui S; Ahmad AE
Urol Oncol; 2021 May; 39(5):258-267. PubMed ID: 33129674
[TBL] [Abstract][Full Text] [Related]
16. Rethinking cancer clinical trials for COVID-19 and beyond.
Doherty GJ; Goksu M; de Paula BHR
Nat Cancer; 2020 Jun; 1(6):568-572. PubMed ID: 35121973
[TBL] [Abstract][Full Text] [Related]
17. Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy.
Riley P; Glenny AM; Worthington HV; Littlewood A; Clarkson JE; McCabe MG
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011552. PubMed ID: 26695736
[TBL] [Abstract][Full Text] [Related]
18. Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.
Smith SM; Wachter K; Burris HA; Schilsky RL; George DJ; Peterson DE; Johnson ML; Markham MJ; Mileham KF; Beg MS; Bendell JC; Dreicer R; Keedy VL; Kimple RJ; Knoll MA; LoConte N; MacKay H; Meisel JL; Moynihan TJ; Mulrooney DA; Mulvey TM; Odenike O; Pennell NA; Reeder-Hayes K; Smith C; Sullivan RJ; Uzzo R
J Clin Oncol; 2021 Apr; 39(10):1165-1184. PubMed ID: 33527845
[No Abstract] [Full Text] [Related]
19. Consequences of COVID-19 for cancer care - a CRUK perspective.
Greenwood E; Swanton C
Nat Rev Clin Oncol; 2021 Jan; 18(1):3-4. PubMed ID: 33097915
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.
Hirsch C; Park YS; Piechotta V; Chai KL; Estcourt LJ; Monsef I; Salomon S; Wood EM; So-Osman C; McQuilten Z; Spinner CD; Malin JJ; Stegemann M; Skoetz N; Kreuzberger N
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD014945. PubMed ID: 35713300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
